Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 19.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 496,388 shares of the company's stock after purchasing an additional 80,492 shares during the period. Mirae Asset Global Investments Co. Ltd.'s holdings in Keurig Dr Pepper were worth $16,411,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Rise Advisors LLC purchased a new position in Keurig Dr Pepper during the 1st quarter worth $25,000. WPG Advisers LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter valued at about $43,000. Continuum Advisory LLC increased its holdings in shares of Keurig Dr Pepper by 82.5% in the 1st quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock valued at $46,000 after purchasing an additional 602 shares in the last quarter. Global Trust Asset Management LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter valued at about $48,000. Finally, N.E.W. Advisory Services LLC purchased a new position in shares of Keurig Dr Pepper in the 1st quarter valued at about $68,000. Hedge funds and other institutional investors own 93.99% of the company's stock.
Keurig Dr Pepper Stock Performance
NASDAQ:KDP opened at $25.84 on Friday. The company has a current ratio of 0.64, a quick ratio of 0.40 and a debt-to-equity ratio of 0.56. The firm has a 50-day moving average price of $30.16 and a two-hundred day moving average price of $32.52. Keurig Dr Pepper, Inc has a twelve month low of $25.27 and a twelve month high of $37.27. The company has a market capitalization of $35.10 billion, a P/E ratio of 23.07, a price-to-earnings-growth ratio of 1.42 and a beta of 0.43.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, hitting analysts' consensus estimates of $0.49. The business had revenue of $4.16 billion during the quarter, compared to the consensus estimate of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The company's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.45 earnings per share. As a group, research analysts expect that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current fiscal year.
Keurig Dr Pepper Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be issued a dividend of $0.23 per share. The ex-dividend date is Friday, September 26th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 3.6%. Keurig Dr Pepper's payout ratio is 82.14%.
Insider Transactions at Keurig Dr Pepper
In other news, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction dated Thursday, July 17th. The shares were sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the sale, the insider directly owned 82,511 shares in the company, valued at $2,777,320.26. The trade was a 12.70% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Robert James Gamgort sold 7,601 shares of Keurig Dr Pepper stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $35.91, for a total transaction of $272,951.91. Following the sale, the director owned 2,284,568 shares of the company's stock, valued at approximately $82,038,836.88. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 435,601 shares of company stock valued at $14,421,512. Insiders own 0.40% of the company's stock.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on the stock. Cowen reiterated a "hold" rating on shares of Keurig Dr Pepper in a report on Wednesday. Barclays downgraded shares of Keurig Dr Pepper from an "overweight" rating to an "equal weight" rating and cut their price target for the company from $39.00 to $26.00 in a report on Wednesday, September 24th. Citigroup cut their price target on shares of Keurig Dr Pepper from $41.00 to $37.00 and set a "buy" rating for the company in a report on Tuesday, September 16th. TD Cowen cut their price target on shares of Keurig Dr Pepper from $36.00 to $28.00 and set a "hold" rating for the company in a report on Wednesday. Finally, HSBC restated a "hold" rating and set a $30.00 target price (down from $42.00) on shares of Keurig Dr Pepper in a report on Tuesday, August 26th. Ten analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $35.14.
Check Out Our Latest Stock Analysis on Keurig Dr Pepper
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.